BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hagen R, Ghareeb E, Jalali O, Zinn Z. Infantile hemangiomas: what have we learned from propranolol? Current Opinion in Pediatrics 2018;30:499-504. [DOI: 10.1097/mop.0000000000000650] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Do LHD, Maibach H. Pharmacogenomics/updated for precision medicine in dermatology. J Dermatolog Treat 2019;30:410-3. [PMID: 30238807 DOI: 10.1080/09546634.2018.1527434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cuesta AM, Gallardo-Vara E, Casado-Vela J, Recio-Poveda L, Botella LM, Albiñana V. The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases. Int J Mol Sci 2022;23:4217. [PMID: 35457036 DOI: 10.3390/ijms23084217] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Phillips JD, Merrill T, Gardner JR, Thomas Collins R 2nd, Sanchez J, Johnson AB, Eble BK, Hartzell LD, Kincannon JM, Richter GT. Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas. Int J Pediatr 2021;2021:6657796. [PMID: 33679994 DOI: 10.1155/2021/6657796] [Reference Citation Analysis]
4 Çubuk S, Çolak MY. A retrospective analysis of benign paediatric jaw lesions according to new World Health Organization classification. Journal of Cranio-Maxillofacial Surgery 2022. [DOI: 10.1016/j.jcms.2022.03.005] [Reference Citation Analysis]
5 Borst AJ, Nakano TA, Blei F, Adams DM, Duis J. A Primer on a Comprehensive Genetic Approach to Vascular Anomalies. Front Pediatr 2020;8:579591. [PMID: 33194911 DOI: 10.3389/fped.2020.579591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Li W, Wan J, Chen C, Zhou C, Liao P, Hu Q, Hu J, Wang Y, Zhang Y, Peng C, Huang Y, Huang W, Zhang W, Mcleod HL, He Y. Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity. J Mol Med (Berl) 2022. [PMID: 35895125 DOI: 10.1007/s00109-022-02238-8] [Reference Citation Analysis]
7 Giese RA, Turner M, Cleves M, Gardner JR, Richter GT. Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development. Int J Pediatr 2021;2021:6669383. [PMID: 33927773 DOI: 10.1155/2021/6669383] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Xu L, Ba H, Lin H, Zhong L, Li S, Tang W, Ke Z, Ye Z. A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature. Ital J Pediatr 2019;45:135. [PMID: 31685000 DOI: 10.1186/s13052-019-0741-8] [Reference Citation Analysis]
9 Chen X, Guo Y, Wang P, Qiu F, Sun Y, Shi Q, Deng Y, Hu C, Lei S. Efficacy and safety of adrenergic beta-antagonist combined with lasers in the treatment of infantile hemangiomas: a meta-analysis. Pediatr Surg Int 2020;36:1135-47. [PMID: 32647928 DOI: 10.1007/s00383-020-04711-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Polymerou I, Ojala T, Bonou P, Martelius L, Tzifa A. Successful treatment of cardiac haemangiomas with oral propranolol: a case series of two patients. Eur Heart J Case Rep 2019;3:ytz093. [PMID: 31449646 DOI: 10.1093/ehjcr/ytz093] [Reference Citation Analysis]